# FDA Warning Letter: PharmaCanna
> 2023-01-06 · Center for Drug Evaluation and Research | CDER · `a1942cfe401bb73e`
## Letter
- **Company:** PharmaCanna
- **Posted Date:** 2023-01-06
- **Letter Issue Date:** 2023-01-05
- **Issuing Office:** Center for Drug Evaluation and Research | CDER
## Subject
Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*